Literature DB >> 25546292

Assessment of percutaneous transhepatic portal vein embolization with portal vein stenting for perihilar cholangiocarcinoma with severe portal vein stenosis.

Ryota Hyodo1, Kojiro Suzuki, Tomoki Ebata, Tomohiro Komada, Yoshine Mori, Yukihiro Yokoyama, Tsuyoshi Igami, Gen Sugawara, Shinji Naganawa, Masato Nagino.   

Abstract

BACKGROUND: The aim of the present study was to assess the clinical efficiency of portal vein (PV) stenting when performed with preoperative percutaneous transhepatic portal vein embolization (PTPVE) in patients with severe PV stenosis due to tumor invasion.
METHODS: Between 2007 and 2013, four consecutive patients (one male, three females; mean age, 52 years; age range, 25-73 years) with perihilar cholangiocarcinoma and PV stenosis underwent PTPVE and PV stenting. Patients were analyzed with regard to the procedure, hypertrophy of the future remnant liver (FRL), and plasma clearance rate of indocyanine green by the FRL (ICGK-F). Further, the %FRL volume increase in PTPVE was compared between the stenting group and the usual PTPVE group who have perihilar cholangiocarcinomas without PV stenosis.
RESULTS: Preoperative PTPVE with PV stenting was successfully performed and portal flow to the FRL improved after stenting in all four patients. The %FRL volume increase was 18-60% (mean, 34%) in the stenting group and was 12-51% (mean, 21%) in the usual PTPVE group. The ICGK-F value after PTPVE exceeded 0.05 in all four patients. All patients achieved R0 resection.
CONCLUSIONS: Preoperative PTPVE with PV stenting appears to be feasible in cases of severe PV tumor invasion and stenosis. This procedure may allow a broader indication for surgery.
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Percutaneous transhepatic portal vein embolization; Perihilar cholangiocarcinoma; Portal vein stenosis; Stent

Mesh:

Year:  2014        PMID: 25546292     DOI: 10.1002/jhbp.200

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  3 in total

1.  Liver Transection-First Approach in Hepatopancreatoduodenectomy for Hilar Cholangiocarcinoma: A Safe and Secure Technique for the Early Assessment of Curable Resection and Vascular Reconstruction.

Authors:  Takamichi Ishii; Satoru Seo; Takashi Ito; Satoshi Ogiso; Ken Fukumitsu; Toshihiko Masui; Kojiro Taura
Journal:  Ann Surg Oncol       Date:  2020-11-09       Impact factor: 5.344

2.  Right trisectionectomy with en bloc portal vein resection for cholangiocarcinoma after preoperative stenting for main portal vein occlusion.

Authors:  Shin Hwang; Gi-Young Ko
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-05-31

3.  Hepatopancreatoduodenectomy for local recurrence of cholangiocarcinoma after excision of a type IV-A congenital choledochal cyst: a case report.

Authors:  Mihoko Yamada; Tomoki Ebata; Gen Sugawara; Tsuyoshi Igami; Takashi Mizuno; Yuji Shingu; Masato Nagino
Journal:  Surg Case Rep       Date:  2016-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.